about
Rotavirus vaccines--achievements and prospectsFeasibility of neonatal screening for Duchenne muscular dystrophy.Leucocyte sodium pump activity after meals or insulin in normal and obese subjects: cause for increased energetic efficiency in obesity?High levels of energy expenditure in obese women.Treatment of high blood pressure: should clinical practice be based on results of clinical trials?The large studies in hypertension: what have they shown?Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.Implementation of a hypertension control program in the county of North Karelia, FinlandEffect of treatment of hypertension in the primary preventive trial, Göteborg, SwedenRegression of left ventricular hypertrophy during treatment with antihypertensive agents.Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.Antihypertensive treatment with beta-blockers in patients aged over 65.Five year follow-up of effects of treatment of mild and moderate hypertensionExperience with screening newborns for Duchenne muscular dystrophy in Wales.Early diagnosis and secondary prevention of Duchenne muscular dystrophyEffects of antihypertensive agents on blood velocity: implications for atherogenesis.Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke.The effect of hypotensive drugs on the quality of life.The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteriaBeta blockers, lipids, and coronary atherosclerosis: fact or fiction?Metoprolol CR/ZOK--its role and efficacy: a review article.Metoprolol-controlled release, zero order kinetics.Angina pectoris: effective therapy once daily.Initial therapy for mild hypertension.Sotalol, a pure beta-adrenergic blocking agent for treatment of essential hypertension and other cardiovascular diseases.Relationship between hypertension and angina pectoris.Use of beta-adrenergic receptor blockers in blacks.Blood transfusion and organ transplantation.Factors affecting the outcome of corneal transplantation.Practical approach to hypertension. 2. Treatment.The effect of nitrous oxide inactivation of vitamin B12 on rat hepatic folate. Implications for the methylfolate-trap hypothesis.Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.Human Escherichia coli diarrhoea.Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.Management of hypertension and changes in blood pressure level in patients included in the hypertension register of the North Karelia Project.Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
P2860
Q27477995-FE9DF9A4-29BD-4ADC-82E6-F2EF231F3213Q33669276-B1D1D59B-7020-4DB3-B09F-E1605675B4FBQ34073598-4EC5B894-2578-47A6-B5B1-5003D1820EFDQ34284976-F3A13B41-8032-4007-91EB-19DE244E5E3FQ34288100-1A050554-8940-4FC1-AE27-F7D97B70C40AQ34416668-2E141A46-CD36-40FF-8E3F-1FA1B1244258Q34448560-1006F782-2C7B-4EF0-A39A-7E763ADFFBDCQ34505202-24FCDECA-3F3A-4CBF-8B08-0EEFEFB1DF8FQ34516441-3FD6CF6F-2C79-46A9-BB33-1690372990C4Q34516447-ED3DBC4E-BD25-4652-8226-1174305DBFB4Q34516475-BA9FD2A2-DCE6-4973-B386-45FEB7B38B8CQ34763718-BDF85483-8BC1-45CD-8B21-14599E7B658CQ34778694-4A4D74E6-B815-405E-9D2E-E2DC9C996742Q35186224-1EF25125-519D-4E9B-A94A-7674EFFB2F90Q35625596-6FB81FE8-0B6A-469B-B4FB-AAC16FB28BA9Q35775724-0B653A00-6EEF-4DF9-AFCC-251CAAE22E2BQ35898763-63369848-079F-437B-BAF6-46F907069630Q35980670-921BC671-49DF-4012-A8E0-0B5D99A7E19EQ36029410-917B8FD0-E582-47E3-BFCD-7607C8DABE39Q36895392-B0A604F0-52EF-4F7C-A7C7-75535EAE94F8Q37906420-4610AB0A-510E-4E0A-AB0E-BD0C9242F8DCQ38673401-3AB059F7-FD13-4886-B322-D0901314A83DQ39238448-CB62A97F-50F4-4B0A-B503-0A5A723B2C87Q39447236-44EFBB13-9911-4F55-9D19-8C1D2CD7DA90Q39809081-EE3447C2-ED7F-4F5C-9825-4AE2032B6250Q39889627-AC41CCCA-6AAF-442B-A01E-29FEA033B6B2Q41225575-2DC9A293-7191-4599-9F52-C269C5B02969Q41269357-42789D8A-E6F4-4C50-A104-89004B8A6E78Q41314807-1BD63964-08B2-4052-996E-2E83BC0A85F1Q41518299-902725D1-7979-4348-95EB-41DFDD2FFCBBQ41644847-A134C288-E618-4D23-80DA-7ECA7EDDCDE4Q42114162-6A7CE344-90A8-4097-B0D0-3CEB147C9CF0Q43214642-A05B57F6-BDCF-4C6B-BB80-539183886903Q43260485-000B5E88-EE34-47A3-B141-C22563882022Q50592901-AEAB5BE4-430F-4510-BCB4-CC58690320DFQ51663091-FFC69A62-213A-49BE-A018-B32AE54BFB67
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Coronary heart-disease after treatment of hypertension.
@en
Coronary heart-disease after treatment of hypertension.
@nl
type
label
Coronary heart-disease after treatment of hypertension.
@en
Coronary heart-disease after treatment of hypertension.
@nl
prefLabel
Coronary heart-disease after treatment of hypertension.
@en
Coronary heart-disease after treatment of hypertension.
@nl
P2093
P1433
P1476
Coronary heart-disease after treatment of hypertension.
@en
P2093
G Berglund
J Wikstrand
L Wilhelmsen
O Andersson
R Sannerstedt
R Sivertsson
P356
10.1016/S0140-6736(78)90356-2
P407
P577
1978-01-01T00:00:00Z